Cell cycle regulation and proliferation in lichen sclerosus

[1]  N. Bhatia.  Significant upregulation of antimicrobial peptides and proteins in lichen sclerosus , 2011 .

[2]  J. A. van der Laak,et al.  High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva. , 2010, Human pathology.

[3]  J. Brennick,et al.  Immunohistochemical Patterns of ProEx C in Vulvar Squamous Lesions: Detection of Overexpression of MCM2 and TOP2A , 2010, The American journal of surgical pathology.

[4]  S. Theocharis,et al.  MCM proteins as diagnostic and prognostic tumor markers in the clinical setting. , 2010, Histology and histopathology.

[5]  S. Kauppila,et al.  Altered p53 and Bcl‐2 expression in keratinocytes of vulvar lichen sclerosus during pimecrolimus treatment , 2009, The British journal of dermatology.

[6]  J. Leman,et al.  Squamous cell carcinoma arising in extragenital lichen sclerosus , 2009, Clinical and experimental dermatology.

[7]  Wei Gu,et al.  Modes of p53 Regulation , 2009, Cell.

[8]  P. D. de Wilde,et al.  A panel of p16INK4A, MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma , 2008, International journal of cancer.

[9]  T. Gambichler,et al.  Expression of proliferation markers and cell cycle regulators in T cell lymphoproliferative skin disorders. , 2008, Journal of dermatological science.

[10]  S. Baithun,et al.  Human papillomavirus-associated increase in p16INK4A expression in penile lichen sclerosus and squamous cell carcinoma , 2007, The British journal of dermatology.

[11]  M. Raspollini,et al.  A comparative analysis of lichen sclerosus of the vulva and lichen sclerosus that evolves to vulvar squamous cell carcinoma. , 2007, American journal of obstetrics and gynecology.

[12]  D. Anagnostakis,et al.  Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the penis. , 2007, Anticancer research.

[13]  L. Massuger,et al.  MIB1 expression in basal cell layer: a diagnostic tool to identify premalignancies of the vulva , 2007, Modern Pathology.

[14]  L. Dubertret,et al.  Inactivation of the CDKN2A and the p53 tumour suppressor genes in external genital carcinomas and their precursors , 2007, The British journal of dermatology.

[15]  B. Liegl,et al.  p53 immunostaining in lichen sclerosus is related to ischaemic stress and is not a marker of differentiated vulvar intraepithelial neoplasia (d‐VIN) , 2006, Histopathology.

[16]  R. Rouzier,et al.  Superficially Invasive Carcinoma of the Vulva: Diagnosis and Treatment , 2005, Clinical obstetrics and gynecology.

[17]  S Regauer,et al.  Early vulvar lichen sclerosus: a histopathological challenge , 2005, Histopathology.

[18]  P. Hantschmann,et al.  P53 expression in vulvar carcinoma, vulvar intraepithelial neoplasia, squamous cell hyperplasia and lichen sclerosus. , 2005, Anticancer research.

[19]  S. Regauer.  Immune dysregulation in lichen sclerosus. , 2005, European journal of cell biology.

[20]  Michael A. Gonzalez,et al.  Cell‐cycle‐dependent regulation of DNA replication and its relevance to cancer pathology , 2005, The Journal of pathology.

[21]  F. Wojnarowska,et al.  Oxidative stress is implicated in the pathogenesis of lichen sclerosus , 2004, The British journal of dermatology.

[22]  S. Cajal,et al.  Immunohistochemical Staining for p16 and p53 in Premalignant and Malignant Epithelial Lesions of the Vulva , 2004, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[23]  Y. Smith,et al.  Vulvar Lichen Sclerosus , 2004, American journal of clinical dermatology.

[24]  J. Crow,et al.  TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva , 2003, British Journal of Cancer.

[25]  H. Kitchener,et al.  Minichromosome maintenance (Mcm) proteins, cyclin B1 and D1, phosphohistone H3 and in situ DNA replication for functional analysis of vulval intraepithelial neoplasia , 2003, British Journal of Cancer.

[26]  D. Hawkins,et al.  Penile intraepithelial neoplasia: clinical spectrum and treatment of 35 cases , 2002, The British journal of dermatology.

[27]  R. Ramsay,et al.  Overexpression of wild-type p53 in lichen sclerosus adjacent to human papillomavirus-negative vulvar cancer. , 2002, The Journal of investigative dermatology.

[28]  J. Herman,et al.  Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus. , 2002, Human pathology.

[29]  J. Crow,et al.  Cyclin D1 and retinoblastoma protein in vulvar cancer and adjacent lesions , 2001, International Journal of Gynecologic Cancer.

[30]  V. L. Wilson,et al.  Concordant p53 and mdm-2 Protein Expression in Vulvar Squamous Cell Carcinoma and Adjacent Lichen Sclerosus , 2001, Applied immunohistochemistry & molecular morphology : AIMM.

[31]  J. Crow,et al.  Cell cycle proteins as molecular markers of malignant change in vulvar lichen sclerosus , 2001, International Journal of Gynecologic Cancer.

[32]  K. Welsh,et al.  Lichen sclerosus premenarche: autoimmunity and immunogenetics , 2000, The British journal of dermatology.

[33]  F. Wojnarowska,et al.  Lichen sclerosus , 1999, The Lancet.

[34]  M. Mihm,et al.  Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[35]  P. H. Mckee,et al.  Altered p53 expression and epidermal cell proliferation is seen in vulval lichen sclerosus , 1994, Journal of cutaneous pathology.